Commonly used measurement for tumor hypoxia includes HIF-1α immunohistochemistry assessment, oxygen electrode probe, PET radiotracers such as 18F-FMISO, 18F-FAZA, Cu (II)-ATSM. This evidence concerns the gene HIF1A and neoplasm.